SCHEMBL2464343

SCHEMBL2464343

Cc1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Br)cc1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALKBH3 Q96Q83 5/20 0.40
CCR2 P41597 1/20 0.39
POLB P06746 1/20 0.37
TYMS P04818 1/20 0.37
PDE3B Q13370 2/20 0.36
PDE3A Q14432 2/20 0.36
TYMP P19971 2/20 0.36
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CCNE2 O96020 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2462220 0.88 ALKBH3 (0.46) ALKBH3CCR2TYMSTYMPKDM4E
SCHEMBL2462203 0.88 ALKBH3 (0.44) ALKBH3CCR2TYMSPDE3BPDE3A
SCHEMBL2425276 0.88 KDM4E (0.46) ALKBH3KDM4EHPGDALDH1A1
SCHEMBL2462018 0.86 PDE10A (0.40) ALKBH3TYMSPDE3BPDE3AKDM4E
SCHEMBL2456787 0.86 CCR2 (0.43) ALKBH3CCR2POLBKDM4EHPGD
SCHEMBL12325085 0.86 NPSR1 (0.48) ALKBH3CCR2TYMSTYMPKDM4E
SCHEMBL2457171 0.82 ALKBH3 (0.48) ALKBH3CCR2POLBTYMSTYMP
SCHEMBL2461969 0.80 PNP (0.39) KDM4EHPGDALDH1A1CCNE2CCNE1
SCHEMBL2459259 0.79 CCR2 (0.51) ALKBH3CCR2
SCHEMBL2454543 0.79 ADCY10 (0.44) ALKBH3CCR2PDE3BPDE3AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO claimed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed